Filter
953
Filtered Results: 953
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
79
New Publications
285
Language
Document type
No document type
481
Studies & Reports
176
Guidelines
144
Manuals
59
Strategic & Response Plan
56
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Kenya
41
Ethiopia
37
India
32
Uganda
27
Global
25
South Africa
24
Ghana
21
Liberia
21
Nigeria
20
Namibia
20
Rwanda
18
Tanzania
18
Sierra Leone
16
Bangladesh
16
Zambia
16
Malawi
15
Nepal
14
Western and Central Europe
14
Ukraine
11
Zimbabwe
10
Syria
9
Africa
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
South–East Asia Region
6
Latin America and the Carribbean
5
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
425
Clinical Guidelines
57
Key Resources
36
Public Health
34
Pharmacy & Technologies
29
Women & Child Health
23
Capacity Building
4
Toolboxes
AMR
124
Pharmacy
117
COVID-19
54
TB
40
HIV
39
Rapid Response
34
Mental Health
31
Global Health Education
20
Planetary Health
19
Ebola & Marburg
14
Caregiver
14
NTDs
14
Conflict
14
Health Financing Toolbox
13
Malaria
11
Specific Hazards
10
NCDs
10
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
2.0 Rapid Response
2
Zika
2
Social Ethics
1
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
The vision of the new Strategic Action Plan for Strengthening HIS in Myanmar 2017- 2021 is “A strong health information system for a strong health system”. The mission statement of HIS in Myanmar also developed during the strategic planning exercise is “Generating and making accessible compreh...
Health Care Facilities (HCFs) are primarily responsible for management of the healthcare waste generated within the facilities, including activities undertaken by them in the community. The health care facilities, while generating the waste are responsible for segregation, collection, in-house trans...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and drug shop staff can facilitate the use of a broad range ...
Capability and Performance
This is the first national Policy to combat AMR in Cambodia. It was developed based on conclusions and recommendations of a country situaytion analysis.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
